Giovanni Mariggi
Tracked across 1 events · 8 articles · First seen Aug 11, 2026 · Last active Aug 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Vaderis Therapeutics, a clinical-stage biopharmaceutical company focused on rare vascular diseases, announced the closing of an oversubscribed $152 million Series B financing and the initiation of its global Phase 3 HEROIC study. The financing was…
Impact: Co-founder and Partner at Medicxi, Chairman of Vaderis's board. His involvement supports strategic governance.
Aug 11, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Giovanni Mariggi live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard